155 related articles for article (PubMed ID: 27657514)
1. Effect of montelukast on markers of airway remodeling in children with asthma.
Tenero L; Piazza M; Sandri M; Azzali A; Chinellato I; Peroni D; Boner A; Piacentini G
Allergy Asthma Proc; 2016 Sep; 37(5):77-83. PubMed ID: 27657514
[TBL] [Abstract][Full Text] [Related]
2. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
[TBL] [Abstract][Full Text] [Related]
3. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.
Minoguchi K; Kohno Y; Minoguchi H; Kihara N; Sano Y; Yasuhara H; Adachi M
Chest; 2002 Mar; 121(3):732-8. PubMed ID: 11888953
[TBL] [Abstract][Full Text] [Related]
4. Effects of exercise training and montelukast in children with mild asthma.
Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
[TBL] [Abstract][Full Text] [Related]
5. [Effect of montelukast sodium on TGF-beta(1) of peripheral blood mononuclear cells from children with mild persistent asthma].
Hong JG; Dong WF; Zhou XJ
Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):679-84. PubMed ID: 22176903
[TBL] [Abstract][Full Text] [Related]
6. Effects of montelukast on symptoms and eNO in children with mild to moderate asthma.
Lee MY; Lai YS; Yang KD; Chen CJ; Hung CH
Pediatr Int; 2005 Dec; 47(6):622-6. PubMed ID: 16354213
[TBL] [Abstract][Full Text] [Related]
7. Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge.
Kelly MM; Chakir J; Vethanayagam D; Boulet LP; Laviolette M; Gauldie J; O'Byrne PM
Chest; 2006 Sep; 130(3):741-53. PubMed ID: 16963671
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma.
Stelmach I; Jerzynska J; Kuna P
Clin Exp Allergy; 2002 Feb; 32(2):264-9. PubMed ID: 11929492
[TBL] [Abstract][Full Text] [Related]
9. [The effect of triamcinolone, montelukast and formoterol on serum levels of il-4, IgE and clinical parameters in children with asthma].
Stelmach I; Grzelewski T; Majak P; Majak J; Bobrowska M; Jerzyńska J; Kuna P
Pol Merkur Lekarski; 2001 Sep; 11(63):247-51. PubMed ID: 11761821
[TBL] [Abstract][Full Text] [Related]
10. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.
Pizzichini E; Leff JA; Reiss TF; Hendeles L; Boulet LP; Wei LX; Efthimiadis AE; Zhang J; Hargreave FE
Eur Respir J; 1999 Jul; 14(1):12-8. PubMed ID: 10489822
[TBL] [Abstract][Full Text] [Related]
11. Suppression of plasma matrix metalloproteinase-9 following montelukast treatment in childhood asthma.
Chuang SS; Hung CH; Hua YM; Tien CH; Yang KD; Jong YJ; Hsu SH; Lin CS
Pediatr Int; 2007 Dec; 49(6):918-22. PubMed ID: 18045297
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J
Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
[TBL] [Abstract][Full Text] [Related]
13. Montelukast decreases plasma endothelin-1 and serum eosinophil cationic protein levels in paediatric atopic asthma.
Kopriva F; Janostáková A; Jarmila S; Zápalka M; Hajduch M
Clin Drug Investig; 2006; 26(6):351-6. PubMed ID: 17163269
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
Stelmach I; Jerzynska J; Kuna P
J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
[TBL] [Abstract][Full Text] [Related]
15. Effect of montelukast on peripheral airflow obstruction in children with asthma.
Spahn JD; Covar RA; Jain N; Gleason M; Shimamoto R; Szefler SJ; Gelfand EW
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):541-9. PubMed ID: 16680924
[TBL] [Abstract][Full Text] [Related]
16. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
17. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.
Sandrini A; Ferreira IM; Gutierrez C; Jardim JR; Zamel N; Chapman KR
Chest; 2003 Oct; 124(4):1334-40. PubMed ID: 14555563
[TBL] [Abstract][Full Text] [Related]
18. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.
Barnes N; Wei LX; Reiss TF; Leff JA; Shingo S; Yu C; Edelman JM
Respir Med; 2001 May; 95(5):379-86. PubMed ID: 11392579
[TBL] [Abstract][Full Text] [Related]
19. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
20. Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens.
Peroni D; Bodini A; Miraglia Del Giudice M; Loiacono A; Baraldi E; Boner AL; Piacentini G
Allergy; 2005 Feb; 60(2):206-10. PubMed ID: 15647042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
